COVID-19

The ANTICOVID clinical trial finds high-dose prophylactic anticoagulation reduces risk of de novo thrombosis in COVID-19 pneumonia.

New meta-analysis show patient demographics—as well as their pre-existing comorbidities and COVID-19 vaccination status—may significantly define their risk of long-term conditions.

A new survey found the COVID-19 pandemic changed many Americans view of obesity and caused others to consider new weight-loss methods due to their concerns.

A new survey analysis delves into Americans' perspective on the CDC, and local and state health departments, and their handling of the pandemic.

Data presented at the AAAAI annual conference showed that delayed cutaneous reactions were more reported following Moderna COVID-19 vaccination than other vaccines.

The study found that COVID-19-induced sensory distortion is a multifactorial syndrome with distinct phenotypes and can have long-term effects on sensory perception.

Data featured at the AAAAI 2023 Annual Meeting revealed that children with current or prior SARS-CoV-2 infection had more autoantibodies than healthy children.

A study examining the COVID-19 pandemic finds that substance use declined substantially across nearly all categories in 2018-2019 vs 2020 among youth and young adults.

Using data from nearly 2 million US patients with a documented COVID-19 infection, a new study provides an overview of the impact of vaccination, both full and partial, on risk of MACE following infection.

An analysis of data from more than 20,000 adults with a documented COVID-19 infection from Los Angeles, CA has brought forth results the investigators suggest prove the association between COVID-19 infection and increased risk of type 2 diabetes, regardless of vaccination status.

The positivity rate of rhinoviruses and enteroviruses decreased briefly following the onset of the COVID-19 pandemic, but by fall of 2020 resumed almost to pre-pandemic levels.

The mRNA vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) showed no risk of Guillain-Barré syndrome post-vaccination.

Older age and use of various medications, including antibiotics, proton pump inhibitors, and corticosteroids were associated with a higher risk of developing C difficile infections.

A recent research letter identified a correlation between mRNA vaccines for COVID-19 and cases of chronic spontaneous urticaria, although the connection requires further study.

New data from the AHA 2023 Statistical Update suggest more people died from cardiovascular-related causes in 2020 than in any year since 2003.

An FDA panel voted unanimously this week to support harmonizing an annual primary and booster dose, moving public health strategies to reflect the endemic course of COVID-19.

A new review shows a majority of COVID-19 randomized, controlled trial preprints have been published with changes to the components of the original findings.

SARS-CoV-2 infections cause microbiome dysbiosis in patient and possibly an increase in opportunistic pathogens and a decrease in beneficial bacteria.

“Repurposing approved drugs developed for other conditions presents an attractive strategy to identify new treatment options and expand access to potentially lifesaving care,” investigators wrote.

Patients with COVID-19 and CDI had a higher incidence of sepsis, shock, ICU admission, and acute kidney injuries.

Patients with mild infection are not at particular risk for severe, chronic outcomes from long Covid, according to new Israel data.

Gut microbiota diversity was lower in below average responders, while 39.5% of participants had a serological response below the geometric mean.

New data support following existing guidelines for mechanical ventilation in pneumonia from SARS-CoV-2, as mortality rates are similar regardless of cause for pneumonia.

“Although the evolution of COVID-19 is favorable worldwide, multiple variables related to psychological health and the response to stressors seem to have triggered symptomatologic responses in fibromyalgia patients,” investigators stated.

New longitudinal data support bolstered use of booster doses among health care workers in US nursing homes.

This novel concept can benefit patients and clinicians alike by appropriately applying new technologies to identify bacteria more efficiently and decrease the time to optimal therapy.

Meta-analysis data show female, Black and Asian participants are generally underrepresented across studies assessing COVID-19 prevention or treatment strategies.

The indication makes tocilizumab the first monoclonal antibody to be granted full FDA approval to treat the pandemic virus.

New surveillance data from the 2021-22 influenza show the impact of coinfection among younger patients.

Almost 4 years since the beginning of the pandemic, continuous research efforts have begun to paint a better picture of the impact the virus has on the brain and the central nervous system.